{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:59:23Z","timestamp":1792155563960,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de recherche du Quebec Sante","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","atherosclerosis-journal.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.atherosclerosis.2024.117489","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T16:58:58Z","timestamp":1709053138000},"page":"117489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Acute pancreatitis risk in multifactorial chylomicronemia syndrome depends on the molecular cause of severe hypertriglyceridemia"],"prefix":"10.1016","volume":"392","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6327-7048","authenticated-orcid":false,"given":"Simon-Pierre","family":"Guay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Paquette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Taschereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lysanne","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Desgagn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Bouchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Baass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.117489_bib1","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2015.26","article-title":"Chylomicronaemia--current diagnosis and future therapies","volume":"11","author":"Brahm","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117489_bib2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1210\/endrev\/bnab037","article-title":"A modern Approach to dyslipidemia","volume":"43","author":"Berberich","year":"2022","journal-title":"Endocr. Rev."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117489_bib3","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/joim.13016","article-title":"Familial chylomicronemia syndrome: an under-recognized cause of severe hypertriglyceridaemia","volume":"287","author":"Baass","year":"2020","journal-title":"J. Intern. Med."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.117489_bib4","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3390\/metabo13050621","article-title":"Severe hypertriglyceridaemia and chylomicronaemia syndrome-causes, clinical presentation, and therapeutic options","volume":"13","author":"Bashir","year":"2023","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117489_bib5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S2213-8587(19)30264-5","article-title":"Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement","volume":"8","author":"Hegele","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2024.117489_bib6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fendo.2020.00455","article-title":"Genetics of hypertriglyceridemia","volume":"11","author":"Dron","year":"2020","journal-title":"Front. Endocrinol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117489_bib7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jacl.2022.05.064","article-title":"Prevalence, severity and management of hypertriglyceridemia-associated pancreatitis; A 7-year retrospective cohort study at Canadian quaternary care hospitals","volume":"16","author":"Hassanloo","year":"2022","journal-title":"J Clin Lipidol"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2024.117489_bib8","doi-asserted-by":"crossref","first-page":"e3473","DOI":"10.1210\/clinem\/dgab360","article-title":"Rare variants in triglycerides-related genes increase pancreatitis risk in multifactorial chylomicronemia syndrome","volume":"106","author":"Paquette","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2024.117489_bib9","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4158\/EP-2018-0599","article-title":"External validation of a predictive model for acute pancreatitis risk in patients with severe hypertriglyceridemia","volume":"25","author":"Morkos","year":"2019","journal-title":"Endocr. Pract."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117489_bib10","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jacl.2016.02.019","article-title":"Severe hypertriglyceridemia and factors associated with acute pancreatitis in an integrated health care system","volume":"10","author":"Rashid","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2024.117489_bib11","article-title":"Diabetes and younger age are vital and independent risk factors for acute pancreatitis in patients with severe hypertriglyceridemia","volume":"2019","author":"Li","year":"2019","journal-title":"BioMed Res. Int."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.117489_bib12","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.pan.2019.08.002","article-title":"Subsets associated with developing acute pancreatitis in patients with severe hypertriglyceridemia and the severity of pancreatitis","volume":"19","author":"Jo","year":"2019","journal-title":"Pancreatology"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117489_bib13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jacl.2018.10.006","article-title":"Severe hypertriglyceridemia is primarily polygenic","volume":"13","author":"Dron","year":"2019","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117489_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12920-020-0669-2","article-title":"Six years' experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias","volume":"13","author":"Dron","year":"2020","journal-title":"BMC Med. Genom."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2024.117489_bib15","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1161\/ATVBAHA.122.318445","article-title":"Genetic testing for hypertriglyceridemia in academic lipid clinics: implications for precision medicine-brief report","volume":"42","author":"Deshotels","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.117489_bib16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and Genomics and the association for molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.atherosclerosis.2024.117489_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ebiom.2018.11.001","article-title":"Intensive genetic analysis for Chinese patients with very high triglyceride levels: relations of mutations to triglyceride levels and acute pancreatitis","volume":"38","author":"Jin","year":"2018","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2024.117489_bib18","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1161\/ATVBAHA.122.318621","article-title":"Is genetic testing in hypertriglyceridemia useful?","volume":"42","author":"Hegele","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.117489_bib19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S2213-8587(21)00046-2","article-title":"Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial","volume":"9","author":"Gouni-Berthold","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.117489_bib20","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/CIRCULATIONAHA.118.039107","article-title":"Inhibition of angiopoietin-like protein 3 with a monoclonal antibody reduces triglycerides in hypertriglyceridemia","volume":"140","author":"Ahmad","year":"2019","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.117489_bib21","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/ajmg.a.63147","volume":"191","author":"Cruz Marino","year":"2023","journal-title":"Am. J. Med. Genet."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117489_bib22","first-page":"29","article-title":"Genealogy and regional distribution of lipoprotein lipase deficiency in French-Canadians of Quebec","volume":"65","author":"Dionne","year":"1993","journal-title":"Hum. Biol."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2024.117489_bib23","doi-asserted-by":"crossref","first-page":"626","DOI":"10.7326\/M19-0203","article-title":"The chylomicronemia syndrome is most often multifactorial: a narrative review of causes and treatment","volume":"170","author":"Chait","year":"2019","journal-title":"Ann. Intern. Med."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2024.117489_bib24","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1161\/ATVBAHA.120.314168","article-title":"Loss-of-Function CREB3L3 variants in patients with severe hypertriglyceridemia","volume":"40","author":"Dron","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117489_bib25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/EJE-21-1104","article-title":"Hypertriglyceridemia in young adults with a 22q11.2 microdeletion","volume":"187","author":"Blagojevic","year":"2022","journal-title":"Eur. J. Endocrinol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2024.117489_bib26","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1194\/jlr.P052522","article-title":"Adiposity significantly modifies genetic risk for dyslipidemia","volume":"55","author":"Cole","year":"2014","journal-title":"J. Lipid Res."},{"issue":"17","key":"10.1016\/j.atherosclerosis.2024.117489_bib27","doi-asserted-by":"crossref","first-page":"9837","DOI":"10.3390\/ijms23179837","article-title":"Polygenic risk of hypertriglyceridemia is modified by BMI","volume":"23","author":"Esteve-Luque","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117489_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40246-021-00339-y","article-title":"Implementation and implications for polygenic risk scores in healthcare","volume":"15","author":"Slunecka","year":"2021","journal-title":"Hum. Genom."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.117489_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003062","article-title":"Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable Mendelian randomisation analysis","volume":"17","author":"Richardson","year":"2020","journal-title":"PLoS Med."},{"key":"10.1016\/j.atherosclerosis.2024.117489_bib30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13148-016-0304-4","article-title":"Epigenome-wide association study (EWAS) on lipids: the Rotterdam Study","volume":"9","author":"Braun","year":"2017","journal-title":"Clin. Epigenet."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.117489_bib31","first-page":"407","article-title":"A systematic review and metaanalysis of observational studies on the effects of epigenetic factors on serum triglycerides","volume":"66","author":"Mazaheri-Tehrani","year":"2022","journal-title":"Arch Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.117489_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/MOL.0000000000000866","article-title":"Genetic determinants of pancreatitis: relevance in severe hypertriglyceridemia","volume":"34","author":"Hang","year":"2023","journal-title":"Curr. Opin. Lipidol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.117489_bib33","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1053\/j.gastro.2023.01.028","article-title":"Proteome-wide mendelian randomization identifies causal links between blood proteins and acute pancreatitis","volume":"164","author":"Bourgault","year":"2023","journal-title":"Gastroenterology"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024000492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024000492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:10:57Z","timestamp":1728922257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915024000492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":33,"alternative-id":["S0021915024000492"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.117489","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute pancreatitis risk in multifactorial chylomicronemia syndrome depends on the molecular cause of severe hypertriglyceridemia","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.117489","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117489"}}